Trial Profile
Antibody-mediated immune response after immunization with FSME-Immun(R) against Tick Borne Encephalitis(TBE) after hematopoietic autologous and allogeneic stem cell transplantation.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 18 Dec 2014
Price :
$35
*
At a glance
- Drugs Tick-borne encephalitis vaccine (Primary)
- Indications Encephalitis virus infections
- Focus Pharmacodynamics
- 21 Nov 2014 New trial record